Quick Menu

Upcoming Journals

International Journal of Medical and Pharmaceutical Case Reports

International Journal of Medical and Pharmaceutical Case Reports, 2394-109X,Vol.: 8, Issue.: 2

Case Study

Linezolid Therapy – A Cause of Bone Marrow Suppression in a Child


Vanny Arora1, Anju Aggarwal1*, Sonali Verma1 and Manish Narang1

1Department of Pediatrics, University College of Medical Sciences and Guru Tegh Bahadur Hospital, New Delhi -110095, India.


Article Information
(1) Rakesh Kumar Tiwari, Chapman University School of Pharmacy, Chapman University Harry and Diane Rinker Health Sciences Campus, Irvine, CA, USA.
(1) Naoki Hashimoto, Kindai University, Japan.
(2) Antonio Di Stasi, University of Alabama at Birmingham, USA.
(3) Garba Uthman Sadiq, University of Maiduguri, Nigeria.
Complete Peer review History: http://www.sciencedomain.org/review-history/17485




Aim: To highlight the importance of monitoring rare side effects of commonly used drugs. Linezolid induced bone marrow (BM) suppression is rare side effect of therapy and rarely reported in the pediatrics age group.

Case Description: A seven year old patient, with persistent discharge from skull suture site following surgery, developed bone marrow suppression 28 days following the start of treatment with Linezolid. BM suppression was fully reversible following discontinuation of Linezolid and all cell lines returned to near baseline 2 weeks after the discontinuation of the drug.

Discussion: The potent activity of Linezolid against Gram-positive bacteria, and its excellent bioavailability after oral dosing, have made it an important addition to the antibiotic armamentarium. Linezolid is relatively a safer drug and BM suppression is a rarely reported side effect, which is particularly observed when the drug is administered for more than 14 days. 

Conclusion: Case highlights the importance of weekly monitoring of complete blood counts in patients who receive Linezolid for more than 14 days.


Keywords :

Linezolid; bone marrow suppression; pediatric population.


Full Article - PDF    Page 1-4    Article Metrics


DOI : 10.9734/IJMPCR/2016/30081

Review History    Comments

Search this site

Advanced Search

Announcement & News

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...


  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.